Beyond Meat Signs Supply Deals With McDonald's, Yum

Partnerships with fast-food giants are set to take meat alternatives further into the dining mainstream.

 
Tesla Temporarily Halted U.S. Production Over Parts Shortage

Elon Musk says car maker paused activity at its U.S. plant because of parts shortages but has restarted operations.

 
German Regulator Steps Down, EY Changes Leadership Following Wirecard Scandal

The Wirecard scandal is leading to more high-profile exits in Germany.

 
Salesforce Posts Record Sales

The business software provider posted record sales and lifted its outlook for the current year.

 
ByteDance Agrees to $92 Million Settlement With U.S. TikTok Teens

The proposed settlement in the U.S. District Court for the Northern District of Illinois could end a set of lengthy disputes over whether the popular video-sharing app unlawfully harvested minors' personal information.

 
Vale Posts Fourth-Quarter Profit Despite Dam Disaster Settlement

Brazilian mining giant Vale SA reported a net profit in the fourth quarter, despite the multibillion-dollar impact of a legal settlement stemming from the Brumadinho dam disaster.

 
Canada's Georgian Partners Eyes Big Fund for Follow-On Deals

Georgian Partners, a prominent Canadian venture firm, is raising up to 1 billion Canadian dollars, equivalent to about US$800 million, for a new fund that will be used to reinvest in a small number of its portfolio companies, according to people familiar with the situation.

 
Chip Makers Applaud Biden's Catch-Up Effort but See No Quick Fix

Industry executives welcomed the U.S. push to fix supply shortages but don't expect immediate results, citing surging demand, the growing use of semiconductors and complex supply chains.

 
AT&T Carves Out Pay-TV Business in Deal With TPG

AT&T agreed to sell a stake in its pay-TV unit to private-equity firm TPG and carve out the struggling business, pulling the telecom giant back from a costly wager on entertainment.

 
Life Sciences Venture Investor Foresite Capital Raises $969 Million

Life sciences venture investor Foresite Capital raised the money through two new funds after placing successful bets on emerging industries such as biotechnology, genomics and synthetic biology.

(END) Dow Jones Newswires

February 25, 2021 23:15 ET (04:15 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.